p-Cresyl Sulfate
T Gryp, R Vanholder, M Vaneechoutte, G Glorieux - Toxins, 2017 - mdpi.com
If chronic kidney disease (CKD) is associated with an impairment of kidney function, several
uremic solutes are retained. Some of these exert toxic effects, which are called uremic …
uremic solutes are retained. Some of these exert toxic effects, which are called uremic …
Understanding the interaction of polyelectrolyte architectures with proteins and biosystems
K Achazi, R Haag, M Ballauff… - Angewandte Chemie …, 2021 - Wiley Online Library
The counterions neutralizing the charges on polyelectrolytes such as DNA or heparin may
dissociate in water and greatly influence the interaction of such polyelectrolytes with …
dissociate in water and greatly influence the interaction of such polyelectrolytes with …
Uremic toxins and their relation with oxidative stress induced in patients with CKD
A Pieniazek, J Bernasinska-Slomczewska… - International Journal of …, 2021 - mdpi.com
The presence of toxins is believed to be a major factor in the development of uremia in
patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Uremic …
patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Uremic …
Exploring protein binding of uremic toxins in patients with different stages of chronic kidney disease and during hemodialysis
O Deltombe, W Van Biesen, G Glorieux, Z Massy… - Toxins, 2015 - mdpi.com
As protein binding of uremic toxins is not well understood, neither in chronic kidney disease
(CKD) progression, nor during a hemodialysis (HD) session, we studied protein binding in …
(CKD) progression, nor during a hemodialysis (HD) session, we studied protein binding in …
Uremic toxins and their relation to dialysis efficacy
Toxin retention is felt to be a major contributor to the development of uremia in patients with
advanced chronic kidney disease and end-stage renal disease (ESRD). Uremic retention …
advanced chronic kidney disease and end-stage renal disease (ESRD). Uremic retention …
Clinical management of the uraemic syndrome in chronic kidney disease
R Vanholder, D Fouque, G Glorieux… - The lancet Diabetes & …, 2016 - thelancet.com
The clinical picture of the uraemic syndrome is a complex amalgam of accelerated ageing
and organ dysfunction, which progress in parallel to chronic kidney disease. The uraemic …
and organ dysfunction, which progress in parallel to chronic kidney disease. The uraemic …
Future avenues to decrease uremic toxin concentration
RC Vanholder, S Eloot, GLRL Glorieux - American Journal of Kidney …, 2016 - Elsevier
In this article, we review approaches for decreasing uremic solute concentrations in chronic
kidney disease and in particular, in end-stage renal disease (ESRD). The rationale to do so …
kidney disease and in particular, in end-stage renal disease (ESRD). The rationale to do so …
Challenges of reducing protein-bound uremic toxin levels in chronic kidney disease and end stage renal disease
M Faria, MN de Pinho - Translational Research, 2021 - Elsevier
The prevalence of chronic kidney disease (CKD) in the worldwide population is currently
estimated between 11% and 13%. Adequate renal clearance is compromised in these …
estimated between 11% and 13%. Adequate renal clearance is compromised in these …
From portable dialysis to a bioengineered kidney
MK van Gelder, SM Mihaila, J Jansen… - Expert review of …, 2018 - Taylor & Francis
Introduction: Since the advent of peritoneal dialysis (PD) in the 1970s, the principles of
dialysis have changed little. In the coming decades, several major breakthroughs are …
dialysis have changed little. In the coming decades, several major breakthroughs are …
Interaction of proteins with polyelectrolytes: Comparison of theory to experiment
We discuss recent investigations of the interaction of polyelectrolytes with proteins. In
particular, we review our recent studies on the interaction of simple proteins such as human …
particular, we review our recent studies on the interaction of simple proteins such as human …